Dear All, if you want to check the spatial expression pattern of a gene in tumors, or if you want to know the intercellular signaling activities for over 1000 secreted proteins in your samples, please try our SecAct framework: https://t.co/bl8K4xIVMZ
🚨 Out today in Cell! @CellCellPress
Path2Space: #AI that predicts spatial transcriptomics (ST) from H&E pathology, enabling spatial biomarker discovery in #BreastCancer at scale.
📄 https://t.co/GtrmH9zIDs
🧵1/8
Our Cell paper is online (https://t.co/t5bOxlCN8q)! We present the CIDE framework, broadly applicable to cancer research and oncology. Also, we highlight AOAH as a promising new immunotherapy.
Delighted to announce the publication of our 10 hallmarks of AI in precision oncology Review paper in Nature Cancer! This work provides a comprehensive, up-to-date synthesis of AI’s transformative role in cancer care. Check it out here: https://t.co/DiU1W66MAo
🎙️ Tune in to Cancer HealthCast! Discussing our latest AI tool predicting immunotherapy responses, as well as the NCI/CCR Synthesis Clinical Trial this fall and its impact on the treatment of aggressive breast cancer. Listen here: https://t.co/pXmJ1krFFl
How do we uncover cell-cell interactions from #SpatialTranscriptomics data? Excited to share Niche-DE (https://t.co/0LSSqYgodz). Niche-DE asks how does a cell’s transcriptome depend on its spatial neighbors, by identifying Niche-Differentially Expressed genes. 1/9
Recently published: @bei2ru@PengJiang20 @NCIEytanRuppin develop Spatial Cellular Estimator for Tumors (SpaCET) to infer cell types and ligand-receptor interactions from #SpatialTranscriptomics data in cancer
#CancerResearch @natrescancer
https://t.co/swplfEXITu
We have released the SpaCET package for cell lineage deconvolution and cell-cell interaction inference in Tumor Spatial Transcriptomics:
https://t.co/5R7aYMMinR
Welcome to try our package: https://t.co/SwcmEjzZre
Congratulations to Dr. Beibei Ru and Dr. Jinlin Huang.
What are the big-data analyses that transformed the understanding, diagnosis & treatment decisions of cancer?
The next challenges to push this even further? & a compilation of all the major big-data resources to assist in this.
Our review's full version: https://t.co/DY5oJbI8Sx
We are very excited to release our Tres framework to evaluate T-cell anti-tumor efficacy, and FIBP as a candidate immunotherapy target.
The paper is published on Nature Medicine: https://t.co/mCLCIEwdcY
The Tres server is available at: https://t.co/skcWXvnBh3
Discover immunotherapy biomarkers from single-cell cytometry data: https://t.co/FgxFzpyg69
A short preview article we wrote to highlight a recent publication and briefly summary the relevant literature.
We are very excited to release our CytoSig web framework to help immunologists with cytokine signaling research.
The paper is published on Nature Methods: https://t.co/LMwdxHU96F
The CytoSig server is available at: https://t.co/3WW4gfkUDN